Article info

Download PDFPDF
High-dose oral methylprednisolone for the treatment of multiple sclerosis relapses: cost-minimisation analysis and patient’s satisfaction

Authors

  1. Correspondence to Mrs. Ana María Horta-Hernández, Pharmacy Department, Hospital Universitario de Guadalajara, Guadalajara 19002, Spain; amhorta{at}sescam.jccm.es
View Full Text

Citation

Horta-Hernández AM, Esaclera-Izquierdo B, Yusta-Izquierdo A, et al
High-dose oral methylprednisolone for the treatment of multiple sclerosis relapses: cost-minimisation analysis and patient’s satisfaction

Publication history

  • Received January 10, 2018
  • Revised March 13, 2018
  • Accepted April 10, 2018
  • First published April 28, 2018.
Online issue publication 
August 30, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.